Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like Sankamap Provides Update on Late Filing of Financial... January 14, 2026 Andy Schectman: Silver Price Breaking Out, Room to... January 14, 2026 Cobalt Market 2025 Year-End Review January 14, 2026 Iron Ore Price Forecast: Top Trends for Iron... January 14, 2026 CoTec to Host Investor Update January 14, 2026 Pentagon Deal Seeks to Create First Large-scale US... January 13, 2026 Rare Earths Market Forecast: Top Trends for Rare... January 13, 2026 Valeura Energy Inc. Announces Q4 2025 Update and... January 13, 2026 Doug Casey: Gold, Silver, Uranium, Oil/Gas — My... January 13, 2026 Heliostar Provides 2026 Guidance and Growth Plan January 13, 2026